₹ 322.41 Cr
2.38%
BSE Healthcare TRI
INF0QA701995
500.0
100.0
500
FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW | - | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.75 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 7.53 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 6.29 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 5.45 |
| FORTIS HEALTHCARE LIMITED. EQ | 3.83 |
| NEULAND LABORATORIES LIMITED EQ | 3.78 |
| BIOCON LIMITED EQ | 3.59 |
| Aurobindo Pharma Limited October 2025 Future | 3.44 |
| Dr. Reddys Laboratories Ltd | 3.43 |
| EMCURE PHARMACEUTICALS LIMITED EQ | 3.26 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 82.74 |
| Fast Moving Consumer Goods | 7.09 |
| Financial Services | 2.15 |
| Capital Goods | 1.68 |
| Consumer Services | 1.21 |
| Chemicals | 0.44 |